353 related articles for article (PubMed ID: 34937557)
1. Patients' and clinicians' perceptions of oral anticoagulants in atrial fibrillation: a systematic narrative review and meta-analysis.
Osasu YM; Cooper R; Mitchell C
BMC Fam Pract; 2021 Dec; 22(1):254. PubMed ID: 34937557
[TBL] [Abstract][Full Text] [Related]
2. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
[TBL] [Abstract][Full Text] [Related]
3. Factors Affecting Patients' Perception On, and Adherence To, Anticoagulant Therapy: Anticipating the Role of Direct Oral Anticoagulants.
Pandya EY; Bajorek B
Patient; 2017 Apr; 10(2):163-185. PubMed ID: 27438598
[TBL] [Abstract][Full Text] [Related]
4. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
López-López JA; Sterne JAC; Thom HHZ; Higgins JPT; Hingorani AD; Okoli GN; Davies PA; Bodalia PN; Bryden PA; Welton NJ; Hollingworth W; Caldwell DM; Savović J; Dias S; Salisbury C; Eaton D; Stephens-Boal A; Sofat R
BMJ; 2017 Nov; 359():j5058. PubMed ID: 29183961
[No Abstract] [Full Text] [Related]
5. Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study.
Durand M; Schnitzer ME; Pang M; Carney G; Eltonsy S; Filion KB; Fisher A; Jun M; Kuo IF; Renoux C; Paterson JM; Quail J; Matteau A;
CMAJ Open; 2020; 8(4):E877-E886. PubMed ID: 33355273
[TBL] [Abstract][Full Text] [Related]
6. Clinicians' views and experiences of prescribing oral anticoagulants for stroke prevention in atrial fibrillation: A qualitative meta-synthesis.
Pritchett RV; Clarke JL; Jolly K; Clarkesmith D; Bem D; Turner GM; Thomas GN; Lane DA
PLoS One; 2020; 15(5):e0232484. PubMed ID: 32379847
[TBL] [Abstract][Full Text] [Related]
7. Oral anticoagulants: a systematic overview of reviews on efficacy and safety, genotyping, self-monitoring, and stakeholder experiences.
Khouja C; Brunton G; Richardson M; Stokes G; Blanchard L; Burchett H; Khatwa M; Walker R; Wright K; Sowden A; Thomas J
Syst Rev; 2022 Oct; 11(1):232. PubMed ID: 36303235
[TBL] [Abstract][Full Text] [Related]
8. Self-reported adherence to direct oral anticoagulants versus warfarin therapy in a specialized thrombosis service-a cross-sectional study of patients in a Canadian Health Region.
Bonsu KO; Young SW; Lee T; Nguyen HV; Chitsike RS
Eur J Clin Pharmacol; 2023 Jan; 79(1):117-125. PubMed ID: 36399203
[TBL] [Abstract][Full Text] [Related]
9. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
10. Use of direct oral anticoagulants for stroke prevention in elderly patients with nonvalvular atrial fibrillation.
Oertel LB; Fogerty AE
J Am Assoc Nurse Pract; 2017 Sep; 29(9):551-561. PubMed ID: 28805310
[TBL] [Abstract][Full Text] [Related]
11. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation Therapy for Atrial Fibrillation in Patients With Alzheimer's Disease.
Ruiz Vargas E; Sposato LA; Lee SAW; Hachinski V; Cipriano LE
Stroke; 2018 Dec; 49(12):2844-2850. PubMed ID: 30571418
[TBL] [Abstract][Full Text] [Related]
13. Meta-Analysis Comparing Direct Oral Anticoagulants Versus Warfarin in Morbidly Obese Patients With Atrial Fibrillation.
Kido K; Shimizu M; Shiga T; Hashiguchi M
Am J Cardiol; 2020 Jul; 126():23-28. PubMed ID: 32345473
[TBL] [Abstract][Full Text] [Related]
14. Trends in anticoagulant prescribing: a review of local policies in English primary care.
Ho KH; van Hove M; Leng G
BMC Health Serv Res; 2020 Apr; 20(1):279. PubMed ID: 32245380
[TBL] [Abstract][Full Text] [Related]
15. Barriers and enablers to adherence to anticoagulation in heart failure with atrial fibrillation: patient and provider perspectives.
Ferguson C; Inglis SC; Newton PJ; Middleton S; Macdonald PS; Davidson PM
J Clin Nurs; 2017 Dec; 26(23-24):4325-4334. PubMed ID: 28178370
[TBL] [Abstract][Full Text] [Related]
16. Direct oral anticoagulants in atrial fibrillation following cardiac surgery: a systematic review and meta-analysis with trial sequential analysis.
Koh KK; Ling RR; Tan SYS; Chen Y; Fan BE; Shekar K; Sule JA; Subbian SK; Ramanathan K
Br J Anaesth; 2022 Aug; 129(2):154-162. PubMed ID: 35729010
[TBL] [Abstract][Full Text] [Related]
17. Can Direct Oral Anticoagulants Be Used for Stroke Prevention Among Patients with Valvular Atrial Fibrillation?
Anderson SL; Marrs JC
Curr Cardiol Rep; 2019 Aug; 21(10):118. PubMed ID: 31473836
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Web-based education resources informing patients about stroke prevention in atrial fibrillation.
Pandya E; Bajorek BV
J Clin Pharm Ther; 2016 Dec; 41(6):667-676. PubMed ID: 27704588
[TBL] [Abstract][Full Text] [Related]
19. Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?
Alamneh EA; Chalmers L; Bereznicki LR
Am J Cardiovasc Drugs; 2016 Jun; 16(3):183-200. PubMed ID: 26862063
[TBL] [Abstract][Full Text] [Related]
20. Warfarin adherence and anticoagulation control in atrial fibrillation patients: a systematic review.
Ababneh M; Nasser SA; Rababa'h A; Ababneh F
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):7926-7933. PubMed ID: 34982455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
